Raymond James analyst Andrew Cooper added Haemonetics (HAE) to the firm’s Analyst Current Favorites list. The list contains the current favorite stock ideas from the firm’s equity analysts. An analyst may only have one “buy” idea on the list at any given time.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HAE:
- Haemonetics upgraded to Strong Buy from Outperform at Raymond James
- Haemonetics’ Q2 2025 Earnings Show Strong Growth
- Haemonetics backs FY25 adjusted EPS view $4.45-$4.75, consensus $4.59
- Haemonetics reports Q2 adjusted EPS $1.12, consensus $1.07
- HAE Earnings Report this Week: Is It a Buy, Ahead of Earnings?